Results 101 to 110 of about 93,748 (310)

Author response for "Genetic risk of hyperuricemia in hypertensive patients associated with antihypertensive drug therapy: a longitudinal study"

open access: gold, 2021
Yu Chen   +11 more
openalex   +1 more source

Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon‐like peptide‐1 receptor agonists. European Journal of Heart Failure expert consensus document

open access: yesEuropean Journal of Heart Failure, EarlyView.
There is growing clinical interest in strategies for improving clinical outcomes in patients with heart failure (HF) and obesity. The development of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and of the dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 RA has expanded therapeutic options for this population. This expert consensus
Luca Monzo   +13 more
wiley   +1 more source

Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat [PDF]

open access: bronze, 2014
Bruno Igreja   +6 more
openalex   +1 more source

Pharmacologic pitfalls in heart failure: A guide to drugs that may cause or exacerbate heart failure. A European Journal of Heart Failure expert consensus document

open access: yesEuropean Journal of Heart Failure, EarlyView.
Main categories of harmful drugs in heart failure. CCB, calcium channel blocker; DPP4i, dipeptidyl peptidase‐4 inhibitor; HER2‐TT, human epidermal growth factor receptor 2‐targeted therapy; NSAID, non‐steroidal anti‐inflammatory drug; TKI, tyrosine kinase inhibitor; TZD, thiazolidinedione; VEGF Inh, vascular endothelial growth factor inhibitor.
Amr Abdin   +16 more
wiley   +1 more source

Adherence to guideline‐directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy

open access: yesEuropean Journal of Heart Failure, EarlyView.
Heart failure (HF) affects over 60 million individuals globally. Contemporary guideline‐directed medical therapies (GDMT) reduce cardiovascular mortality and HF hospitalizations. However, medication non‐adherence represents a critical barrier limiting real‐world efficacy of GDMT.
Gianluigi Savarese   +37 more
wiley   +1 more source

Asymmetric Catalytic Hydrogenation toward a Value‐Added Chiral Building Block: Optically Active γ‐Butyrolactone Scaffold from Renewable and Synthetic Derived Feedstocks

open access: yesEuropean Journal of Organic Chemistry, EarlyView.
This brief compendium summarizes the most successful asymmetric hydrogenation strategies for the preparation of chiral monocyclic γ‐lactone derivatives from keto acids and keto esters, with emphasis on their relevance for large‐scale production and high enatioselectivities. This article provides a brief compendium on the production of chiral monocyclic
Marta Feliz, Maria J. Sabater
wiley   +1 more source

Prevalence of gingival overgrowth induced by antihypertensive drugs: A hospital-based study

open access: diamond, 2015
Saumiya Gopal   +5 more
openalex   +1 more source

Cardiovascular morbidity following epilepsy: A nationwide retrospective cohort study in South Korea

open access: yesEpilepsia Open, EarlyView.
Abstract Objective This study evaluated the long‐term risk of major cardiovascular diseases (CVDs) in patients with epilepsy using a nationwide cohort, aiming to address critical gaps in population‐based evidence on brain–heart interactions. Methods Data from the Korean National Health Insurance Service (2002–2013) were analyzed.
Youngoh Bae   +5 more
wiley   +1 more source

Gambaran Penggunaan Obat Antihipertensi pada Pasien Geriatri Rawat Jalan dengan Penyakit Kardiovaskular

open access: yesIndonesian Journal of Pharmaceutical Education
In Indonesia, in 2023 the geriatric population will reach 10.48% of the total population of Indonesia. The risk of cardiovascular disease increases with age.
Reza Rahmawati   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy